Abstract
Abstract  In this study, seeking further information on the role of the nociceptin/orphanin FQ (N/OFQ)‐ergic system in normal and disturbed colonic motor function in rats, we compared the colonic effects of UFP‐112, a novel highly potent agonist, with those of N/OFQ. When injected intracerebroventricularly (i.c.v.) and intraperitoneally (i.p.), UFP‐112 and N/OFQ increased bead expulsion time in a statistically significant and dose‐related manner and reduced the percentage of rats with castor oil‐induced diarrhoea. UFP‐112 showed greater efficacy, higher potency and longer‐lasting inhibitory effects than N/OFQ, and pretreatment with UFP‐101, a selective antagonist, blocked the N/OFQ analogue‐induced responses in both tests. When injected i.c.v., UFP‐112 and N/OFQ inhibited corticotrophin releasing factor‐ and restrain stress‐stimulated faecal pellet excretion significantly and in a dose‐related manner. Conversely, when injected peripherally both peptides significantly inhibited colonic propulsive motility but did so in a non‐dose‐related manner. In conclusion, these findings indicate that, in the rat, the central and peripheral N/OFQ systems have an inhibitory role in modulating distal colonic propulsive motility under physiological and pathological conditions. UFP‐112 therefore promises to be a useful pharmacological tool for investigating the role of the N/OFQ system in motor functions in the distal colonic tract under physiological and pathological conditions.

This publication has 43 references indexed in Scilit: